Susquehanna Fundamental Investments’s Madrigal Pharmaceuticals MDGL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-2,186
| Closed | -$584K | – | 979 |
|
|
2024
Q1 | $584K | Buy |
+2,186
| New | +$584K | 0.03% | 442 |
|
|
2023
Q1 | – | Sell |
-2,507
| Closed | -$728K | – | 1046 |
|
|
2022
Q4 | $728K | Buy |
+2,507
| New | +$728K | 0.01% | 751 |
|
|
2022
Q1 | $685K | Sell |
6,985
-3,618
| -34% | -$355K | 0.01% | 974 |
|
|
2021
Q4 | $898K | Buy |
10,603
+1,962
| +23% | +$166K | 0.02% | 697 |
|
|
2021
Q3 | $689K | Buy |
+8,641
| New | +$689K | 0.01% | 1054 |
|
|
2021
Q2 | – | Sell |
-2,068
| Closed | -$242K | – | 1720 |
|
|
2021
Q1 | $242K | Buy |
+2,068
| New | +$242K | ﹤0.01% | 1351 |
|